Biotage AB
STO:BIOT

Watchlist Manager
Biotage AB Logo
Biotage AB
STO:BIOT
Watchlist
Price: 159.9 SEK -0.93% Market Closed
Market Cap: 12.7B SEK
Have any thoughts about
Biotage AB?
Write Note

Biotage AB
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Biotage AB
Net Income Peer Comparison

Comparables:
ALIF B
BICO
G
GENO
MCAP
M
MAGLE

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Biotage AB
STO:BIOT
Net Income
kr327m
CAGR 3-Years
8%
CAGR 5-Years
9%
CAGR 10-Years
20%
AddLife AB
STO:ALIF B
Net Income
kr339m
CAGR 3-Years
-20%
CAGR 5-Years
16%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Net Income
-kr1.7B
CAGR 3-Years
-214%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Genovis AB
STO:GENO
Net Income
kr23.2m
CAGR 3-Years
41%
CAGR 5-Years
38%
CAGR 10-Years
N/A
MedCap AB (publ)
STO:MCAP
Net Income
kr294.3m
CAGR 3-Years
38%
CAGR 5-Years
33%
CAGR 10-Years
58%
M
Magle Chemoswed Holding AB
STO:MAGLE
Net Income
kr15.1m
CAGR 3-Years
49%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Biotage AB's Net Income?
Net Income
327m SEK

Based on the financial report for Sep 30, 2024, Biotage AB's Net Income amounts to 327m SEK.

What is Biotage AB's Net Income growth rate?
Net Income CAGR 10Y
20%

Over the last year, the Net Income growth was 35%. The average annual Net Income growth rates for Biotage AB have been 8% over the past three years , 9% over the past five years , and 20% over the past ten years .

Back to Top